Core E, Virology, Proteomics and Microbial Pathogenesis (VPMP), is the main resource provided by the CFAR to support virological investigations of HIV and studies of its co-pathogens, Mycobacterium tuberculosis (MTB) and Hepatitis C Virus (HCV). The Core has been newly configured to provide a wide range of services in support of modern virology research that now includes mass spectrometry, live cell sorting, and proteomics, novel services for the rapid production of recombinant viruses, as well as state-of- the-art biosafety facilities, that include high throughput live cell sort facilities for infectious samples.
The specific aims of the Virology, Proteomics and Microbial Pathogenesis core are: ? Virology: Provide recombinant HIV viruses using novel recombination methods in yeast recently developed by the Arts laboratory to rapidly generate viruses with desired properties. Provide access to a virus repository carrying a collection of over 500 well-characterized primary HIV isolates. Provide training to enhance the use of recombinant HlV-1 strains. ? Proteomics: Operate mass spectrometry, proteomics facilities and provide a systems biology and bioinformatics infrastructure to support a wide range of projects in HIV/AIDS research currently funded by the NIH. Specifically, proteomic services focus on protein abundance measurements, identification of post-translational modifications, structural proteomics analysis, and pathway analysis. Provide training to enhance the use and understanding of role of advanced Proteomics and Bioinformatics technologies in HIV research. ? Microbial Pathogenesis: Provide fully managed, well-equipped, and safe working environments (Biosafety level 2+ and 3) for the study of HIV, virulent MTB, and HCV, including live cell sorting (LCS) facilities for separation of HIV-infected, HCV-infected, and MTB-infected mononuclear cells. Safety monitoring, management, and training will be provide to the entire CFAR including the Uganda Laboratory Core C. Develop and provide quantitative PCR assays to monitor pathogen growth. Train and monitor researchers in Biosafety laboratories, and in the use of PCR methodologies for pathogen detection.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-JBS-A)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Case Western Reserve University
United States
Zip Code
Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372
Tomalka, Amanda G; Resto-Garay, Ivelisse; Campbell, Kerry S et al. (2018) In vitro Evidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T Cells. Front Immunol 9:2552
Kalayjian, Robert C; Albert, Jeffrey M; Cremers, Serge et al. (2018) Women have enhanced bone loss associated with phosphaturia and CD4+ cell restoration during initial antiretroviral therapy. AIDS 32:2517-2524
AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018) Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS 32:2777-2786
Mbonye, Uri; Wang, Benlian; Gokulrangan, Giridharan et al. (2018) Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation. J Biol Chem 293:10009-10025
Sayin, Ismail; Radtke, Andrea J; Vella, Laura A et al. (2018) Spatial distribution and function of T follicular regulatory cells in human lymph nodes. J Exp Med 215:1531-1542
Elion, Richard A; Althoff, Keri N; Zhang, Jinbing et al. (2018) Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV. J Acquir Immune Defic Syndr 78:62-72
Martinez, Leonardo; Shen, Ye; Handel, Andreas et al. (2018) Effectiveness of WHO's pragmatic screening algorithm for child contacts of tuberculosis cases in resource-constrained settings: a prospective cohort study in Uganda. Lancet Respir Med 6:276-286
Grover, Surbhi; Desir, Fidel; Jing, Yuezhou et al. (2018) Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis. J Acquir Immune Defic Syndr 79:421-429
Kityo, Cissy; Makamdop, Krystelle Nganou; Rothenberger, Meghan et al. (2018) Lymphoid tissue fibrosis is associated with impaired vaccine responses. J Clin Invest 128:2763-2773

Showing the most recent 10 out of 539 publications